1.390
-0.010
(-0.71%)
At close: 11:34:08 AM GMT+8
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -1.76 | -1.47 |
| Low Estimate | 0 | 0 | -1.76 | -1.47 |
| High Estimate | 0 | 0 | -1.76 | -1.47 |
| Year Ago EPS | -- | -- | -1.25 | -1.76 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 183M | 319M |
| Low Estimate | -- | -- | 183M | 319M |
| High Estimate | -- | -- | 183M | 319M |
| Year Ago Sales | -- | -- | 173.86M | 183M |
| Sales Growth (year/est) | -- | -- | 5.26% | 74.32% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -1.76 | -1.47 |
| 7 Days Ago | 0 | 0 | -1.77 | -1.48 |
| 30 Days Ago | 0 | 0 | -1.77 | -1.48 |
| 60 Days Ago | 0 | 0 | -1.77 | -1.48 |
| 90 Days Ago | 0 | 0 | -1.77 | -1.48 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 2126.HK | -- | -- | -40.78% | 16.48% |
| S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Related Tickers
1GDA.F Zevra Therapeutics, Inc.
7.85
+6.08%
471A.F aTyr Pharma, Inc.
3.2800
-4.09%
PH4.F CStone Pharmaceuticals
0.2800
-2.10%
CVAC.VI CureVac N.V.
3.7560
+4.16%
2Q5.BE Enochian BioSciences Inc
0.8000
+3.49%
HQ1.MU Oruka Therapeutics Inc. R
11.20
-5.08%
GYX.F Futura Medical plc
0.3400
-10.99%
ORN.F Oryzon Genomics S.A.
1.4260
-2.73%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4670
-5.08%
25I.F ImmuPharma plc
0.0815
+16.43%